BELS Springboard, Sustaining, Charter & Founding Members

BELS Members who support the organization at a higher level to help accelerate our progress.

BELS Springboard Contributors

BELS greatly appreciates our most generous members. Springboard Contributors help put BELS on a firmer financial footing and enable delivery of expanded programming to encourage greater collaboration and faster progress, and supporting our work to extend the global reputation, reach and impact of the UK life sciences sector which is so critical to the UK economy. 

 Clive MeanwellFounder & Former CEO, The Medicines Company, Parsippany, NJ

BELS Sustaining Members

BELS gratefully acknowledges our Sustaining Members who generously support BELS. Their investment in the organisation helps to support the planning and delivery of BELS activities and to extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.

Mark Bamforth, President & CEO, Arranta Bio, Cambridge MA

Dan Bradbury, Managing Member, BioBrit; Executive Chair & Co-founder Equillium, La Jolla, CA

Tim Clackson, President & Chief Technology Officer, Xilio Therapeutics, Waltham, MA   

  David Ebsworth Chair of Supervisory Board, Synlab, Munich, Germany

Andrew Parkinson, Chief Executive Officer, XPD Consulting, Shawnee, Kansas

BELS Charter Members

BELS gratefully acknowledges our Charter Members who champion the BELS cause and help support its operation with an enhanced commitment on an annual basis.

 Bruce Carter, Board Director

Sean McCarthy, CEO, CytomX Therapeutics, South San Francisco, CA

Mark Stevenson, Executive Vice President & Chief Operating Officer, Thermo Fisher Scientific, Waltham, MA

BELS Founding Members

BELS gratefully acknowledges our early Founding Members who generously supported BELS financially to help us re-launch BELS globally in 2016. Their contributions have helped extend the UK’s heritage of scientific excellence in the spirit of collaboration, innovation and kinship.

Mark Bamforth, President & CEO, Arranta Bio, Cambridge MA

Dr Dominic P Behan, President & CEO, Sentia Medical Sciences, San Diego CA

Dr Simon Blake, Sr Director, Scientific Licensing, Immunology, Janssen Research & Development, Berwyn PA

Dr Timothy P Clackson, President & EVP R&D – Xilio Therapeutics, Cambridge MA

Nicola Downes, Chief Financial Officer, uLab Systems, Redwood City CA

Dr David R Ebsworth, Chairman, Verona Pharma and Actimed Therapeutics, Switzerland

Dr Christopher H Evans, Professor & Director of Rehabilitation Medicine Research Center, Mayo Clinic, Rochester MN

Dr Clive A Meanwell, Ex Chief Executive Officer, The Medicines Company, Parsippany NJ

Dr Stephen Naylor, Chairman & CEO, MaiHealth, Indianapolis IN